Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-17-028955
Filing Date
2017-12-18
Accepted
2017-12-18 12:20:37
Documents
1
Period of Report
2017-12-14

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4681
  Complete submission text file 0000899243-17-028955.txt   6355
Mailing Address 10025 INVESTMENT DRIVE SUITE 250 KNOXVILLE TN 37932
Business Address 10025 INVESTMENT DRIVE SUITE 250 KNOXVILLE TN 37932 865-769-4011
PROVECTUS BIOPHARMACEUTICALS, INC. (Issuer) CIK: 0000315545 (see all company filings)

EIN.: 900031917 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 7327 OAK RIDGE HIGHWAY SUITE A KNOXVILLE TN 37931
Business Address
Glass John R (Reporting) CIK: 0001672946 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36457 | Film No.: 171260864